282 related articles for article (PubMed ID: 30083270)
21. Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity.
Sakemura R; Bansal A; Siegler EL; Hefazi M; Yang N; Khadka RH; Newsom AN; Hansen MJ; Cox MJ; Manriquez Roman C; Schick KJ; Can I; Tapper EE; Nevala WK; Adada MM; Bezerra ED; Kankeu Fonkoua LA; Horvei P; Ruff MW; Parikh SA; Pandey MK; DeGrado TR; Suksanpaisan L; Kay NE; Peng KW; Russell SJ; Kenderian SS
Cancer Immunol Res; 2021 Sep; 9(9):1035-1046. PubMed ID: 34244299
[TBL] [Abstract][Full Text] [Related]
22. The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy.
Kitzberger C; Spellerberg R; Morath V; Schwenk N; Schmohl KA; Schug C; Urnauer S; Tutter M; Eiber M; Schilling F; Weber WA; Ziegler S; Bartenstein P; Wagner E; Nelson PJ; Spitzweg C
EJNMMI Res; 2022 May; 12(1):25. PubMed ID: 35503582
[TBL] [Abstract][Full Text] [Related]
23. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
24. Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborate.
Marti-Climent JM; Collantes M; Jauregui-Osoro M; Quincoces G; Prieto E; Bilbao I; Ecay M; Richter JA; Peñuelas I
EJNMMI Res; 2015 Dec; 5(1):70. PubMed ID: 26635227
[TBL] [Abstract][Full Text] [Related]
25. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
26. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies.
Penheiter AR; Russell SJ; Carlson SK
Curr Gene Ther; 2012 Feb; 12(1):33-47. PubMed ID: 22263922
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
[TBL] [Abstract][Full Text] [Related]
28. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
29. Inter-species variation in monovalent anion substrate selectivity and inhibitor sensitivity in the sodium iodide symporter (NIS).
Concilio SC; Zhekova HR; Noskov SY; Russell SJ
PLoS One; 2020; 15(2):e0229085. PubMed ID: 32084174
[TBL] [Abstract][Full Text] [Related]
30. Regulation and tissue distribution of the human sodium iodide symporter gene.
Ajjan RA; Kamaruddin NA; Crisp M; Watson PF; Ludgate M; Weetman AP
Clin Endocrinol (Oxf); 1998 Oct; 49(4):517-23. PubMed ID: 9876351
[TBL] [Abstract][Full Text] [Related]
31. Functional Radionuclide Imaging, In-Vitro Radioiodine Uptake Estimation and RT-PCR in the Evaluation of Sodium Iodide Symporter (NIS) Expression and Functionality in Breast Cancer: A Pilot Study.
Joseph JK; Patel RB; Damle AA; Nair N; Badwe RA; Basu S
Indian J Surg Oncol; 2013 Mar; 4(1):80-91. PubMed ID: 24426705
[TBL] [Abstract][Full Text] [Related]
32. A new PET probe, (18)F-tetrafluoroborate, for the sodium/iodide symporter: possible impacts on nuclear medicine.
Youn H; Jeong JM; Chung JK
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2105-7. PubMed ID: 20821208
[No Abstract] [Full Text] [Related]
33. Iodinated Contrast Agents Perturb Iodide Uptake by the Thyroid Independently of Free Iodide.
Vassaux G; Zwarthoed C; Signetti L; Guglielmi J; Compin C; Guigonis JM; Juhel T; Humbert O; Benisvy D; Pourcher T; Cambien B
J Nucl Med; 2018 Jan; 59(1):121-126. PubMed ID: 29051343
[TBL] [Abstract][Full Text] [Related]
34. [The practical relevance of the sodium iodide symporter].
Spitzweg C
Z Arztl Fortbild Qualitatssich; 2004 May; 98 Suppl 5():25-32. PubMed ID: 15255310
[TBL] [Abstract][Full Text] [Related]
35. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Carvalho DP; Ferreira AC
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
[TBL] [Abstract][Full Text] [Related]
36. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
Josefsson M; Grunditz T; Ohlsson T; Ekblad E
Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
[TBL] [Abstract][Full Text] [Related]
37. Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond.
Santhanam P; Solnes LB; Rowe SP
Med Oncol; 2017 Oct; 34(12):189. PubMed ID: 29086115
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
39. [(18)F]tetrafluoroborate as a PET tracer for the sodium/iodide symporter: the importance of specific activity.
Khoshnevisan A; Jauregui-Osoro M; Shaw K; Torres JB; Young JD; Ramakrishnan NK; Jackson A; Smith GE; Gee AD; Blower PJ
EJNMMI Res; 2016 Dec; 6(1):34. PubMed ID: 27103614
[TBL] [Abstract][Full Text] [Related]
40. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
